Insurer Says Clients on Daily Pill Have Stayed H.I.V.-Free
In one of the first and largest evaluations of the use of preexposure prophylaxis (PrEP) to prevent HIV infection in a clinical practice setting, researchers at Kaiser Permanente found no new HIV infections among patients during more than 2.5 years of observation. The study was published on Sept. 2, 2015 in the journal Clinical Infectious Diseases.
Type 1 Diabetes Linked to Higher Risk of Dementia
People with type 1 diabetes may face a greater risk of developing thinking and memory problems as they age compared to the general population, new research suggests.
Study finds overweight and obese patients get less cancer-fighting drugs per pound of body weight and could suffer the consequences
Overweight patients with ovarian cancer are often given less chemotherapy per pound of body weight in order to reduce the toxic side effects associated with higher doses. This may lower their chances of survival according to new research.
Turning spit and data into treasure
100,000 members of Kaiser Permanente anonymously share DNA and medical records with researchers. Data is being analyzed by the Genetic Epidemiology Research on Adult Health and Aging (GERA). This interview and three papers explain the genotyping research to date.
Kaiser Permanente to Share Expertise at White House Event Kicking Off National Plan to Fight the Growth of Superbugs
The Permanente Medical Group uses advanced technology to guide prescribing practice and maximize the impact of effective antibiotic use of commonly over-treated conditions.
U.S. News & World Report Names Ten Kaiser Permanente Northern California Hospitals Among Nation’s Highest Performing
10 Kaiser Permanente hospitals in Northern California were rated high performing by the U.S. News & World Report Best Hospitals for Common Care.